Filing Flows › Iradimed (IRMD) › Q2 2026 › vs Q1 2026
Iradimed (IRMD) Q2 2026 vs Q1 2026 (quarter over quarter)
Iradimed's revenue fell $1.5M (-7%) from $22.0M in Q1 2026 to $20.5M in Q2 2026. The biggest changes: Total devices revenue −$1.6M (-10%); Ferro Magnetic Detection Systems +$135K (+22%); Disposables −$92K (-2%). Gross margin 74.1% against 76.5% (-2.4 pts).
Iradimed, Q2 2026: revenue $20.5M (+0.3% year over year), operating margin 31.2%, net earnings $5.2M, operating cash flow $5.9M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 74.1% | 76.5% | -2.4 pts |
| Operating margin | 31.2% | 32.9% | -1.7 pts |
| Net margin | 25.5% | 26.5% | -1.0 pts |
| Free cash flow margin | 28.1% | 35.9% | -7.8 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| MRI Compatible Patient Vital Signs Monitoring Systems | $6.7M | $7.1M | −$442K | -6% |
| MRI Compatible IV Infusion Pumps | $6.4M | $7.7M | −$1.2M | -16% |
| Amortized Revenue | $758K | $659K | $99K | +15% |
| Total devices revenue | $13.9M | $15.4M | −$1.6M | -10% |
| Disposables | $4.8M | $4.9M | −$92K | -2% |
| Services and other | $1.1M | $1.0M | $23K | +2% |
| Ferro Magnetic Detection Systems | $756K | $621K | $135K | +22% |
| Revenue | $20.5M | $22.0M | −$1.5M | -7% |
| Gross profit | $15.2M | $16.8M | −$1.7M | -10% |
| Cost of revenue | $5.3M | $5.2M | $141K | +3% |
| Other income, net | $497K | $532K | −$35K | -7% |
| Operating profit | $6.4M | $7.2M | −$846K | -12% |
| Operating expenses | $8.8M | $9.6M | −$808K | -8% |
| Pre-tax earnings | $6.9M | $7.8M | −$881K | -11% |
| Research & development | $657K | $956K | −$299K | -31% |
| Sales & marketing | $4.2M | $4.1M | $194K | +5% |
| General & admin | $3.9M | $4.6M | −$703K | -15% |
| Net earnings | $5.2M | $5.8M | −$600K | -10% |
| Income tax | $1.7M | $2.0M | −$281K | -14% |
| Depreciation & amortization | $410K | $455K | −$45K | -10% |
| Share-based compensation | $807K | $684K | $123K | +18% |
| Working capital & other | $495K | −$1.3M | $1.8M | — |
| Operating cash flow | $5.9M | $8.3M | −$2.4M | -28% |
| Free cash flow (OCF − capex) | $5.8M | $7.9M | −$2.1M | -27% |
| Capital expenditures | $185K | $403K | −$218K | -54% |
Questions
How much did Iradimed's revenue grow quarter over quarter in Q2 2026?
Iradimed's revenue fell $1.5M (-7%) from $22.0M in Q1 2026 to $20.5M in Q2 2026.
What drove Iradimed's revenue change in Q2 2026?
Total devices revenue −$1.6M (-10%); Ferro Magnetic Detection Systems +$135K (+22%); Disposables −$92K (-2%).